Clinical Trial: Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An Efficacy and Safety Study of Intravenous Pantoprazole in the Prevention of Recurrent Peptic Ulcer Bleeding After Successful Hemostasis
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of intravenous pantoprazole in the prevention of rebleeding in patients with bleeding peptic ulcer disease after successful endoscopic hemostatic therapy.
Detailed Summary:
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Wyeth is now a wholly owned subsidiary of Pfizer
Dates:
Date Received: June 26, 2002
Date Started: April 2001
Date Completion:
Last Updated: February 7, 2013
Last Verified: February 2013